These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 21641074)
1. A review of Health Technology Assessment (HTA) recommendations for drug therapies issued between 2007 and 2009 and their impact on policymaking processes in Poland. Kolasa K; Schubert S; Manca A; Hermanowski T Health Policy; 2011 Oct; 102(2-3):145-51. PubMed ID: 21641074 [TBL] [Abstract][Full Text] [Related]
2. Health technology assessment in Poland and Scotland: comparison of process and decisions. Kolasa K; Wasiak R Int J Technol Assess Health Care; 2012 Jan; 28(1):70-6. PubMed ID: 22617739 [TBL] [Abstract][Full Text] [Related]
3. Health technology assessment: research trends and future priorities in Europe. Nielsen CP; Funch TM; Kristensen FB J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525 [TBL] [Abstract][Full Text] [Related]
4. From idealistic rookies to a regional leader: the history of health technology assessment in Poland. Nizankowski R; Wilk N Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():156-62. PubMed ID: 19527537 [TBL] [Abstract][Full Text] [Related]
5. The impact of health technology assessment reports on decision making in Austria. Zechmeister I; Schumacher I Int J Technol Assess Health Care; 2012 Jan; 28(1):77-84. PubMed ID: 22233544 [TBL] [Abstract][Full Text] [Related]
6. Health technology assessment of public health programmes in Poland, years 2010 and 2013. Kolasa K; Turlej A; Hermanowski T Przegl Epidemiol; 2016; 70(1):77-81, 151-4. PubMed ID: 27344479 [TBL] [Abstract][Full Text] [Related]
7. AOTMiT reimbursement recommendations compared to other HTA agencies. Mela A; Lis D; Rdzanek E; Jaroszyński J; Furtak-Niczyporuk M; Drop B; Blicharski T; Niewada M Eur J Health Econ; 2024 Nov; 25(8):1291-1310. PubMed ID: 38261131 [TBL] [Abstract][Full Text] [Related]
8. Integration of health technology assessment recommendations into organizational and clinical practice: A case study in Catalonia. Gagnon MP; Sánchez E; Pons JM Int J Technol Assess Health Care; 2006; 22(2):169-76. PubMed ID: 16571192 [TBL] [Abstract][Full Text] [Related]
9. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries. Oortwijn W; Mathijssen J; Banta D Health Policy; 2010 May; 95(2-3):174-84. PubMed ID: 20074829 [TBL] [Abstract][Full Text] [Related]
10. Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland. Allen N; Walker SR; Liberti L; Salek S Value Health; 2017 Mar; 20(3):320-328. PubMed ID: 28292476 [TBL] [Abstract][Full Text] [Related]
11. History of health technology assessment in Belgium. Cleemput I; Van Wilder P Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():82-7. PubMed ID: 19500438 [TBL] [Abstract][Full Text] [Related]
12. A DECADE OF HEALTH TECHNOLOGY ASSESSMENT IN POLAND. Lipska I; McAuslane N; Leufkens H; Hövels A Int J Technol Assess Health Care; 2017 Jan; 33(3):350-357. PubMed ID: 28720170 [TBL] [Abstract][Full Text] [Related]
13. A determination of topics for health technology assessment in Thailand: making decision makers involved. Lertpitakpong C; Chaikledkaew U; Thavorncharoensap M; Tantivess S; Praditsitthikorn N; Youngkong S; Yothasamut J; Udomsuk K; Sinthitichai K; Teerawattananon Y J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S100-9. PubMed ID: 19253492 [TBL] [Abstract][Full Text] [Related]
14. Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries. Kolasa K; Kalo Z; Zah V; Dolezal T Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):283-7. PubMed ID: 22812552 [TBL] [Abstract][Full Text] [Related]
15. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792 [TBL] [Abstract][Full Text] [Related]
16. Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand? Tarride JE; McCarron CE; Lim M; Bowen JM; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R Int J Technol Assess Health Care; 2008; 24(4):437-44. PubMed ID: 18828938 [TBL] [Abstract][Full Text] [Related]
17. Trends and determinants in reimbursement decision-making in Poland in the years 2013-2015. Kawalec P; Malinowski KP; Trąbka W Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):197-205. PubMed ID: 28952400 [TBL] [Abstract][Full Text] [Related]
19. Historical development of health technology assessment in Thailand. Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543 [TBL] [Abstract][Full Text] [Related]
20. Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA. Kristensen FB; Lampe K; Chase DL; Lee-Robin SH; Wild C; Moharra M; Garrido MV; Nielsen CP; Røttingen JA; Neikter SA; Bistrup ML; Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():1-8. PubMed ID: 20030885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]